Analysis of Risk Factors for Urinary Tract Infection in Ovarian Cancer Patients After Cytoreductive Surgery and Construction of a Nomogram Model. [PDF]
Int J Womens HealthHe M, Li J, Huang L, Liang F.
europepmc +1 more source
Prognostic Factors and Nomogram-Based Prediction Models for Colorectal Cancer Patients With Synchronous Peritoneal Metastasis Undergoing Cytoreductive Surgery: A Retrospective Cohort Study. [PDF]
Cancer MedGe X +11 more
europepmc +1 more source
Letter to "Risk factors affecting prognosis in pseudomyxoma peritonei patients after hyperthermic intraperitoneal chemotherapy and cytoreductive surgery". [PDF]
Int J SurgFan Q, Jia L.
europepmc +1 more source
Long-term outcomes of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and its relevant risk factors in China: a retrospective study. [PDF]
Front SurgGao S, Zhang X, Yu Z, Zhang J.
europepmc +1 more source
Understanding nutrition challenges and information needs of women undergoing cytoreductive surgery for ovarian cancer: a study protocol for an experience-based co-design methodology. [PDF]
Support Care CancerCherry K +7 more
europepmc +1 more source
Correction to "Implementation of a Multidisciplinary Enhanced Recovery After Surgery (ERAS) Program for Cytoreductive Surgery (CRS) With Hyperthermic Intraperitoneal Chemotherapy (HIPEC)". [PDF]
J Surg Oncoleuropepmc +1 more source
Related searches:
PURPOSE To evaluate the relative effect of percent maximal cytoreductive surgery and other prognostic variables on survival among cohorts of patients with advanced-stage ovarian carcinoma treated with platinum-based chemotherapy.
R. Bristow +4 more
semanticscholar +1 more source
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is predominantly performed and studied in academic centers. While developing CRS/HIPEC programs in nonacademic hospitals can increase accessibility, its safety and ...
A. Nikiforchin +6 more
semanticscholar +1 more source